Cerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samplesReportar como inadecuado

Cerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samples - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Alzheimer-s Research and Therapy

, 5:47

First Online: 14 October 2013Received: 19 July 2013Accepted: 03 October 2013


IntroductionThe neuronal loss in Alzheimer disease AD has been described to affect grey matter in the cerebral cortex. However, in the elderly, AD pathology is likely to occur together with subcortical axonal degeneration on the basis of cerebrovascular disease. Therefore, we hypothesized that biomarkers for AD and subcortical axonal degeneration would correlate in patients undergoing testing for dementia biomarkers, particularly in older age groups.

MethodsWe performed correlation and cluster analyses of cerebrospinal fluid CSF biomarker data from 5,542 CSF samples analyzed in our routine clinical neurochemistry laboratory in 2010 through 2012 for the established CSF AD biomarkers total tau T-tau, phosphorylated-tau P-tau, amyloid β1-42 Aβ42, and for neurofilament light NFL, which is a protein expressed in large-caliber myelinated axons, the CSF levels of which correlate with subcortical axonal injury.

ResultsAβ42, T-tau, and P-tau correlated with NFL. By cluster analysis, we found a bimodal data distribution in which a group with a low Aβ42-P-tau ratio suggesting AD pathology had high levels of NFL. High levels of NFL also correlated with the presence of an AD biomarker pattern defined by Aβ42-P-tau and T-tau. Only 29% of those with an AD biomarker signature had normal NFL levels. Age was a possible confounding factor for the associations between NFL and established AD biomarkers, but in a logistic regression analysis, both age and NFL independently predicted the AD biomarker pattern.

ConclusionsThe association between an AD-like signature using the established biomarkers Aβ42, T-tau, and P-tau with increased levels of NFL provides in vivo evidence of an association between AD and subcortical axonal degeneration in this uniquely large dataset of CSF samples tested for dementia biomarkers.

AbbreviationsADAlzheimer disease


Aβ42Amyloid β1-42

CCCCubic clustering criterion

CSFCerebrospinal fluid

CVCoefficient of variation

NFLNeurofilament light

P-tauPhosphorylated tau

T-tauTotal tau.

Electronic supplementary materialThe online version of this article doi:10.1186-alzrt212 contains supplementary material, which is available to authorized users.

Download fulltext PDF

Autor: Tobias Skillbäck - Henrik Zetterberg - Kaj Blennow - Niklas Mattsson

Fuente: https://link.springer.com/

Documentos relacionados